AP-1 subunits: Quarrel and harmony among siblings

Journal of Cell Science

Volumn 117, Issue 25, 2004, Pages 5965-5973

  Hess, Jochen ^a   Angel, Peter ^a   Schorpp Kistner, Marina ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

AP 1; ATF; Fos; Jun; Subunits; Transcription

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CYCLIN A; CYCLIN D1; CYTOKINE; DIMER; GROWTH FACTOR; JANUS KINASE; NUCLEAR FACTOR; PROTEIN C JUN; PROTEIN FOS; PROTEIN P16; PROTEIN P19; PROTEIN P21; PROTEIN P53; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BONE CELL; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CELL TYPE; CHRONIC MYELOID LEUKEMIA; DEVELOPMENT; FIBROSARCOMA; GENE CONTROL; HODGKIN DISEASE; HUMAN; KERATINOCYTE; LIVER CELL; LIVER CELL CARCINOMA; LYMPHOID CELL; MALIGNANT TRANSFORMATION; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; DIMERIZATION; HEPATOCYTES; HUMANS; KERATINOCYTES; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

BACTERIA (MICROORGANISMS); JANUS;

EID: 12344252237     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01589     Document Type: Article

References (91)

1. Agarwal, S. K., Guru, S. C., Heppner C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M. et al. (1999). Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96, 143-152.
2. Agarwal, S. K., Novotny, E. A., Crabtree, J. S., Weitzman, J. B., Yaniv, M., Burns, A. L., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M. and Marx, S. J. (2003). Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc. Natl. Acad. Sci. USA 100, 10770-10775.
3. Ameyar M., Wisniewska, M. and Weitzman, J. B. (2003). A role for AP-1 in apoptosis: the case for and against. Biochimie 85, 747-752.
4. Andrecht, S., Kolbus, A., Hartenstein, B., Angel, P. and Schorpp-Kistner, M. (2002). Cell cycle promoting activity of JunB through cyclin A activation. J. Biol. Chem. 277, 35961-35968.
5. Angel, P. and Karin, M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.
6. Bakiri, L., Matsuo, K., Wisniewska, M., Wagner, E. F. and Yaniv, M. (2002). Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 22, 4952-4964.
7. Baumann, S., Hess, J., Eichhorst, S. T., Krueger, A., Angel, P., Krammer, P. H. and Kirchhoff, S. (2003). An unexpected role for FosB in activation-induced cell death of T cells. Oncogene 22, 1333-1339.
8. Behrens, A., Sibilia, M. and Wagner, E. F. (1999). Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21, 326-329.
9. Behrens, A., Jochum, W., Sibilia, M. and Wagner, E. F. (2000). Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19, 2657-2663.
10. Behrens, A., Sabapathy, K., Graef, I., Cleary, M., Crabtree, G. R. and Wagner, E. F. (2001). Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). Proc. Natl. Acad. Sci. USA 98, 1769-1774.
11. Behrens, A., Sibilia, M., David, J. P., Mohle-Steinlein, U., Tronche, F., Schutz, G. and Wagner, E. F. (2002). Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J. 21, 1782-1790.
12. Behrens, A., Haigh, J., Mechta-Grigoriou, F., Nagy, A., Yaniv, M. and Wagner, E. F. (2003). Impaired intervertebral disc formation in the absence of Jun. Development 130, 103-109.
13. Beier, F., Lee, R. J., Taylor, A. C., Pestell, R. G. and LuValle, P. (1999). Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc. Natl. Acad. Sci. USA 96, 1433-1438.
14. Beier, F., Taylor, A. C. and LuValle, P. (2000). Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. J. Biol. Chem. 275, 12948-12953.
15. Bouillet, P. and Strasser, A. (2002). BH3-only proteins - evolutionarily conserved pro-apoptotic Bcl-2 family members essential for initiating programmed cell death. J. Cell Sci. 115, 1567-1574.
16. Chang, L. and Karin, M. (2001). Mammalian MAP kinase signalling cascade. Nature 410, 37-41.
17. Chen, R. H., Abate, C. and Blenis, J. (1993). Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90 kDa ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 90, 10952-10956.
18. Chen, R. H., Juo, P. C., Curran, T. and Blenis, J. (1996). Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12, 1493-1502.
19. Crist, S. A., Griffith, T. S. and Ratliff, T. L. (2003). Structure/function analysis of the marine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element. J. Biol. Chem. 278, 35950-35958.
20. David, J. P., Sabapathy, K., Hoffmann, O., Idarraga, M. H. and Wagner, E. F. (2002). JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 115, 4317-4325.
21. Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
22. Deng, T. and Karin, M. (1994). c-Fos transcriptional activity stimulated by h-Ras-activated protein kinase distinct from JNK and ERK. Nature 371, 171-175.
23. Eferl, R. and Wagner, E. F. (2003). AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868.
24. Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler A., Kufferath, I., Guertl, B., Zenz, R., Wagner, E. F. and Zatloukal, K. (1999), Functions of c-Jun in liver and heart development. J. Cell Biol. 145, 1049-1061.
25. Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J. P., Rath, M. and Wagner, E. F. (2003). Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181-192.
26. Eferl, R., Hoebertz, A., Schilling, A. F., Rath, M., Karreth, F., Kenner, L., Amling, M. and Wagner, E. F. (2004). The Fos-related antigen Frau-1 is an activator of bone matrix formation. EMBO J. 23, 2789-2799.
27. Eichhorst, S. T., Muller, M., Li-Webeg M., Schulze-Bergkamen, H., Angel, P. and Krammer, P. H. (2000). A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol. Cell. Biol. 20, 7826-7837.
28. Elkeles, A., Juven-Gershon, T., Israeli, D., Wilder, S., Zalcenstein, A. and Oren, M. (1999). The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. Mol. Cell. Biol. 19, 2594-2600.
29. Fleischmann, A., Hafezi, F., Elliot, C., Reme, C. E., Ruther, U. and Wagner, E. F. (2000). Frau-1 replaces c-Fos-dependent functions in mice. Genes Dev. 14, 2695-2700.
30. Fleischmann, A., Jochum, W., Eferl, R., Witowsky, J. and Wagner, E. F. (2003). Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. Cancer Cell 4, 477-482.
31. Florin, L., Hummerich, L., Dittrich, B. T., Kokocinski, F., Wrobel, G., Gack, S., Schorpp-Kistner M., Werner, S., Hahn, M., Lichter, P. et al. (2004). Identification of novel AP-1 target genes in fibroblasts regulated during cutaneous wound healing. Oncogene 23, 7005-7017.
32. Glover, J. N. and Harrison, S. C. (1995). Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373, 257-261.
33. Grigoriadis, A. E., Wang, Z. Q. and Wagner, E. F. (1995). Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet. 11, 436-441.
34. Grimm, C., Wenzel, A., Behrens., A., Hafezi, F., Wagner, E. F. and Reme, C. E. (2001). AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun. Cell Death Differ. 8, 859-867.
35. Hafezi, F., Grimm, C., Wenzel, A., Abegg, M., Yaniv, M. and Reme, C. E. (1999). Retinal photoreceptors are apoptosis-competent in the absence of JunD/AP-1. Cell Death Differ. 6, 934-936.
36. Harris, C. A. and Johnson, E. M., Jr (2001). BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J. Biol. Chem. 276 37754-37760.
37. Hartenstein, B., Teurich, S., Hess, J., Schenkel, J., Schorpp-Kistner, M. and Angel, P. (2002). Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB. EMBO J. 21, 6321-6329.
38. Herdegen, T. and Leah, J. D. (1998). Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28, 370-490.
39. Herdegen, T., Skene, P. and Bahr, M. (1997). The c-Jun transcription factor - bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 20, 227-231.
40. Hess, J., Hartenstein, B., Teurich, S., Schmidt, D., Schorpp-Kistner, M. and Angel, P. (2003). Defective endochondral ossification in mice with strongly compromised expression of JunB. J. Cell Sci. 116, 4587-4596.
41. Hilberg, F., Aguzzi, A., Howells, N. and Wagner, E. F. (1993). c-jun is essential for normal mouse development and hepatogenesis. Nature 365, 179-181.
42. Jochum, W., Passegue, E. and Wagner, E. F. (2001). AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.
43. Johnson, R. S., Spiegelmann, B. M. and Papaioannou, V. (1992). Pleiottropic effects of a null mutation in the c-fos proto-oncogene. Cell 71, 577-586.
44. Kalra, N. and Kumar, V. (2004). c-Fos is a mediator of the c-myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 279, 25313-25319.
45. Karin, M., Liu, Z. and Zandi, E. (1997). AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246.
46. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A. and Green, D. R. (1998). DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol. Cell 1, 543-551.
47. Kenner, L., Hoebertz, A., Beil, T., Keon, N., Karreth, F., Eferl, R., Scheuch, H., Szremska, A., Amling, M., Schorpp-Kistner, M. et al. (2004). Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J. Cell Biol. 164, 613-623.
48. Kolbus, A., Herr, I., Schreiber, M., Debatin, K. M., Wagner, E. F. and Angel, P. (2000). c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol. Cell. Biol. 20, 575-582.
49. Krammer, P. H. (2000). CD95's deadly mission in the immune system. Nature 407, 789-795.
50. Lamb, J. A., Ventura, J. J., Hess, P., Flavell, R. A. and Davis, R. J. (2003). JunD mediates survival signaling by the JNK signal transduction pathway. Mol. Cell 11, 1479-1489.
51. Lasham, A., Lindridge, E., Rudert, F., Onrust, R. and Watson, J. (2000). Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors. Gene 252, 1-13.
52. Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F. X., Green, D. R. and Karin, M. (1999). Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 19, 751-763.
53. Lei, K., Nimnual, A., Zong, W. X., Kennedy, N. J., Flavell, R. A., Thompson, C. B., Bar-Sagi, D. and Davis, R. J. (2002 . The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol. Cell. Biol. 22, 4929-4942.
54. Leppa, S., Eriksson, M., Saffrich, R., Ansorge, W. and Bohmann, D. (2001). Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells. Mol. Cell. Biol. 21 4369-4378.
55. Li, G., Gustafson-Brown, C., Hanks, S. K., Nason, K., Arbeit, J. M., Pogliano, K., Wisdom, R. M. and Johnson, R. S. (2003). c-Jun is essential for organization of the epidermal leading edge. Dev. Cell 4, 865-877.
56. Lin, A. (2003). Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25, 17-24.
57. Matsui, K., Xiao, S., Fine, A. and Ju, S. T. (2000). Role of activator protein-1 in TCR-mediated regulation of the murine fast promoter. J. Immunol. 164, 3002-3008.
58. Matsuo, K., Owens, J. M., Tonko, M., Elliot, C., Chambers, T. J. and Wagner, E. F. (2000). Fos11 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24, 184-187.
59. Meixner, A., Karreth, F., Kenner, L. and Wagner, E. F. (2004). JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO J. 23, 1325-1335.
60. Mikula, M., Gotzmann, J., Fischer, A. N., Wolschek, M. F., Thallinger, C., Schulte-Hermann, R., Beug, H. and Mikulits, W. (2003 . The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene 22, 6725-6738.
61. Nateri A. S., Riera-Sans, L., da Costa, C. and Behrens, A. (2004). The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303, 1374-1378.
62. Palmada, M., Kanwal, S., Rutkoski, N. J., Gustafson-Brown, C., Johnson, R. S., Wisdom, R. and Carter, B. D. (2002). c-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation. J. Cell Biol. 158, 453-461.
63. Passegue, E. and Wagner, E. F. (2000). JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19, 2969-2979.
64. Passegue, E., Jochum, W., Schorpp-Kistner, M., Mohle-Steinlein, U. and Wagner, E. F. (2001). Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell 104, 21-32.
65. Passegue, E., Jochum, W., Behrens, A., Ricci, R. and Wagner, E. F. (2002). JunB can substitute for Jun in mouse development and cell proliferation. Nat. Genet. 30, 158-166.
66. Piu, F., Aronheim, A., Katz, S. and Karin, M. (2001). AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation. Mol. Cell. Biol. 21, 3012-3024.
67. Raivich, G., Bohatschek, M., da Costa, C., Iwata, O., Galiano, M., Hristova, M., Nateri, A. S., Makwana, M., Riera-Sans, L., Wolfer, D. P. et al. (2004). The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43, 57-67.
68. Rich, K. A., Zhan, Y. and Blanks, J. C. (1997). Aberrant expression of c-Fos accompanies photoreceptor cell death in the rd mouse. J. Neurobiol. 32, 593-612.
69. Rincon, M., Whitmarsh, A., Yang, D. D., Weiss, L., Derijard, B., Jayaraj, P., Davis, R. J. and Flavell, R. A. (1998). The JNK pathway regulates the in vivo deletion of immature CD4(+)CD8(+) thymocytes. J. Exp. Med. 188, 1817-1830.
70. Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J. P., Jochum, W., Wagner, E. F. and Karin, M. (1999). JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9, 116-125.
71. Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P. and Wagner, E. F. (1999). Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607-619.
72. Shaulian, E. and Karin, M. (2001). AP-1 in cell proliferation and survival. Oncogene 20, 2390-2400.
73. Shaulian, E. and Karin, M. (2002). AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-E136.
74. Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F. and Karin, M. (2000). The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 103 897-907.
75. Sunters, A., Thomas, D. P., Yeudall, W. A. and Grigoriadis, A. E. (2004). Accelerated cell cycle progression in osteoblasts overexpressing the c-fos proto-oncogene: induction of cyclin A and enhanced CDK2 activity. J. Biol. Chem. 279, 9882-9891.
76. Szabowski, A., Maas-Szabowski, N., Andrecht, S., Kolbus, A., Schorpp-Kistner, M., Fusenig, N. E. and Angel, P. (2000). e-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103, 745-755.
77. Szremska, A. P., Kenner, L., Weisz, E., Ott, R. G., Passegue, E., Artwohl, M., Freissmuth, M., Stoxreiter, R., Theussl, H. C., Parzer, S. B. et al. (2003). JunB inhibits proliferation and transformation in B-lymphoid cells. Blood 102, 4159-4165.
78. Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A. and Davis, R. J. (2000). Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874.
79. Wagner, E. F. (2001). AP-1 reviews. Oncogene 20, 2333-2497.
80. Wagner, E. F. (2002). Functions of AP1 (Fos/Jun) in bone development. Ann. Rheum. Dis. 61, 40-42.
81. Wang, Z. Q., Grigoriadis, A. E., Mohle-Steinlein, U. and Wagner, E. F. (1991). A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J. 10, 2437-2450.
82. Wang, Z. Q., Ovitt, C., Grigoriadis, A. E., Mohle-Steinlein, U., Ruther, U. and Wagner, E. F. (1992). Bone and hematopoietic defects in mice lacking c-fos. Nature 360, 741-745.
83. Weitzman, J. B., Fiette, L., Matsuo, K. and Yaniv, M. (2000). JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell 6, 1109-1119.
84. Wenzel, A., Iseli, H. P., Fleischmann, A., Hafezi, F., Grimm, C., Wagner, E. F. and Reme, C. E. (2002). Fra-1 substitutes for c-Fos in AP-1-mediated signal transduction in retinal apoptosis. J. Neurochem. 80, 1089-1094.
85. Whitfield, J., Neame, S. J., Paquet, L., Bernard, O. and Ham, J. (2001). Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 29, 629-643.
86. Willis, S., Day, C. L., Hinds, M. G. and Huang, D. C. S. (2003). The Bcl-2-regulated apoptotic pathway. J. Cell Sci. 116, 4053-4056.
87. Yang, D. D., Kuan, C. Y., Whitmarsh, A. J., Rincon, M., Zheng, T. S., Davis, R.J., Rakic, P. and Flavell, R. A. (1997). Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870.
88. Yang, M. Y., Liu, T. C., Chang, J. G., Lin, P. M. and Lin, S. F. (2003). JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood 101, 3205-3211.
89. Yin, K. J., Lee, J. M., Chen, S. D., Xu, J. and Hsu, C. Y. (2002). Amyloid-beta induces Smac release via AP-1/Bim activation in cerebral endothelial cells. J. Neurosci. 22, 9764-9770.
90. Zenz, R., Scheuch, H., Martin, P., Frank, C., Eferl, R., Kenner, L., Sibilia, M. and Wagner, E. F. (2003). c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev. Cell 4, 879-889.
91. Zhang, J., Zhang, D., McQuade, J. S., Behbehani, M., Tsien, J. Z. and Xu, M. (2002). c-fos regulates neuronal excitability and survival. Nat. Genet. 30, 416-420.